One-stop cervical cancer screening could save lives of women with HIV in cameroon

NCT ID NCT07177170

Recruiting now Knowledge-focused Sponsor: Institut de Recherche pour le Developpement Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether a single-visit approach to cervical cancer screening and treatment can reduce dropout rates among women living with HIV in Cameroon. Researchers will compare the current multi-visit system with a streamlined process that includes HPV testing and same-day treatment when needed. The goal is to see if this approach is feasible, acceptable, and more effective at completing the full screening cascade.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that a single-visit screening and treatment approach is feasible and acceptable, reducing dropout rates and improving cervical cancer prevention in resource-limited settings.
What could go wrong: This is an early implementation study, not a randomized trial, so results may not be generalizable. The approach may face logistical or cultural barriers, and long-term effectiveness is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER SCREENING HIV

Contacts and locations

Locations

Foumban hospital
RECRUITING

Foumban, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.